Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IDECABTAGENE VICLEUCEL Cause Disease progression? 17 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Disease progression have been filed in association with IDECABTAGENE VICLEUCEL (Abecma). This represents 1.6% of all adverse event reports for IDECABTAGENE VICLEUCEL.

17
Reports of Disease progression with IDECABTAGENE VICLEUCEL
1.6%
of all IDECABTAGENE VICLEUCEL reports
9
Deaths
2
Hospitalizations

How Dangerous Is Disease progression From IDECABTAGENE VICLEUCEL?

Of the 17 reports, 9 (52.9%) resulted in death, 2 (11.8%) required hospitalization.

Is Disease progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IDECABTAGENE VICLEUCEL. However, 17 reports have been filed with the FAERS database.

What Other Side Effects Does IDECABTAGENE VICLEUCEL Cause?

Cytokine release syndrome (607) Immune effector cell-associated neurotoxicity syndrome (176) Fatigue (159) Neurotoxicity (70) Neutropenia (68) Pyrexia (67) Anaemia (63) Decreased appetite (54) Headache (54) Hypogammaglobulinaemia (54)

What Other Drugs Cause Disease progression?

RITUXIMAB (7,282) CYCLOPHOSPHAMIDE (7,100) DOXORUBICIN (6,165) VINCRISTINE (5,252) PREDNISONE (5,096) BEVACIZUMAB (4,653) DEXAMETHASONE (4,545) CARBOPLATIN (4,538) CAPECITABINE (3,808) ETOPOSIDE (3,776)

Which IDECABTAGENE VICLEUCEL Alternatives Have Lower Disease progression Risk?

IDECABTAGENE VICLEUCEL vs IDELALISIB IDECABTAGENE VICLEUCEL vs IDURSULFASE IDECABTAGENE VICLEUCEL vs IFOSFAMIDE IDECABTAGENE VICLEUCEL vs IGURATIMOD IDECABTAGENE VICLEUCEL vs ILOPERIDONE

Related Pages

IDECABTAGENE VICLEUCEL Full Profile All Disease progression Reports All Drugs Causing Disease progression IDECABTAGENE VICLEUCEL Demographics